Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»ýÁãÀÇ ¹ÙÀÌ·¯½º¼º ½É±Ù¿°¿¡¼­ ÇÕº´Áõ µ¿¹Ý À¯¹«¿¡ µû¸¥ Á¶Á÷ ¹× Ç÷û³» ±Ý¼Ó´Ü¹éÈ¿¼Ò¾ïÁ¦ÀÚÀÇ ¹ßÇö Â÷ÀÌ Altered Expression of Tissue Inhibitor of Matrix Metalloproteinase-2 in Complicated Mice Heart Secondary to Experimentally Induced Viral Myocarditis

´ëÇѺ´¸®ÇÐȸÁö 2001³â 35±Ç 3È£ p.196 ~ 200
±è¼º¼÷, ¾ö´ë¿î, ¼­ÀçÈñ, ÇãÁÖ·É, È«¿µ¹Ì, ÃÖÀÎÇ¥,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼º¼÷ ( Kim Sung-Sook ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

¾ö´ë¿î ( Eom Dae-Woon ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼­ÀçÈñ ( Suh Jae-Hee ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇãÁÖ·É ( Huh Joo-Ryung ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
È«¿µ¹Ì ( Hong Young-Mi ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÃÖÀÎÇ¥ ( Choi In-Pyo ) 
Çѱ¹»ý¸í°øÇבּ¸¿ø ºÐÀÚ»ýÀÇÇבּ¸½Ç

Abstract


Background: The pathogenesis of transition from viral myocarditis to dilated cardiomyopathy is elusive, although the incidence of dilated cardiomyopathy in human is increasing.

Methods: To clarify the role of the tissue inhibitor of matrix metaloproteinase-2 (TIMP-2) in this event, we performed immunohistochemistry, immunoblotting and immunoassay of matrix metalloproteinase-9 (MMP-9) and TIMP-2 in the serum and heart tissue of mice, which were inoculated with 4000 plaque-forming units of coxsackie B virus.

Results: The MMP-9 was expressed in damaged cardiomyocytes, and the TIMP-2 was expressed in mainly interstitial connective tissue between cardiac muscle bundles by immunohistochemistry. The level of serum MMP-9 was higher in the complicated than non-complicated group (p<0.001), but the level of TIMP-2 was much lower in complicated than non-complicated group (p<0.05). These findings were similar to the results of immunohistochemistry and immunoblotting in tissues.

Conclusions: These results suggest that an imbalance in the level of MMP-9 and its inhibitor might activate cardiac complication in viral myocarditis.

Å°¿öµå

Myocarditis;Cardiomyopathy;Gelatinase B;Tissue inhibitor of matrix metalloproteinase-2;Immunohistochemistry

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS